Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Larimar Therapeutics, Inc. (LRMR) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-29.61M |
|
-- |
|
-- |
|
$31.12M |
|
$-31.12M |
|
$1.50M |
|
$-29.61M |
|
$-29.61M |
|
$-29.61M |
|
$-29.61M |
|
$-29.61M |
|
$-29.61M |
|
$-31.12M |
|
$-31.13M |
|
89.81M |
|
89.81M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$204.98M |
|
$0.56M |
|
$3.53M |
|
$208.51M |
|
$47.76M |
|
-- |
|
$2.72M |
|
$50.48M |
|
$158.03M |
|
$158.03M |
|
$158.03M |
|
103.88M |
|
| Cash Flow Statement Financials | |
$-44.61M |
|
$29.00M |
|
$108.11M |
|
$86.02M |
|
$178.52M |
|
$92.50M |
|
$1.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.29 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-44.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-18.74% |
|
-18.74% |
|
-14.20% |
|
-18.74% |
|
$1.52 |
|
$-0.50 |
|
$-0.50 |
|